Nano Cap New Millennium Growth Fund L P Buys New Stake in Mettler-Toledo International, Inc. $MTD

Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) during the 4th quarter, Holdings Channel.com reports. The firm bought 525 shares of the medical instruments supplier’s stock, valued at approximately $732,000.

Several other hedge funds and other institutional investors have also made changes to their positions in MTD. Geneos Wealth Management Inc. lifted its holdings in shares of Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 30 shares in the last quarter. Baird Financial Group Inc. boosted its holdings in Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after acquiring an additional 40 shares during the period. Jump Financial LLC boosted its holdings in Mettler-Toledo International by 44.6% in the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock worth $476,000 after acquiring an additional 125 shares during the period. Cerity Partners LLC boosted its holdings in Mettler-Toledo International by 10.8% in the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after acquiring an additional 392 shares during the period. Finally, AXA S.A. boosted its holdings in Mettler-Toledo International by 2.9% in the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after acquiring an additional 131 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

MTD has been the subject of several recent analyst reports. Morgan Stanley lowered their target price on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 12th. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Citigroup dropped their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the stock from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Finally, Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a research note on Monday. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $1,408.55.

Mettler-Toledo International Stock Up 0.9%

Shares of NYSE MTD opened at $1,092.32 on Friday. The stock’s 50 day moving average price is $1,229.96 and its two-hundred day moving average price is $1,344.22. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The stock has a market capitalization of $22.08 billion, a P/E ratio of 25.62, a PEG ratio of 2.26 and a beta of 1.31.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. During the same period last year, the firm posted $8.19 EPS. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.